The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance

Clinical Nuclear Medicine

Volumn 35, Issue 10, 2010, Pages 759-763

  Nam, Hyun Yeol ^a   Kim, Seong Jang ^a   Kim, In Joo ^a   Kim, Bum Soo ^a   Pak, Kyoungjune ^a   Kim, Keunyoung ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

C reactive protein; F 18 FDG; hemoglobin; spleen

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BILE DUCT CARCINOMA; CANCER EPIDEMIOLOGY; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL ARTICLE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; ERYTHROCYTE COUNT; FEMALE; FEMUR FRACTURE; GALLBLADDER CANCER; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; LIVER; LIVER CIRRHOSIS; LUNG CANCER; MALE; MEDICAL RECORD REVIEW; NEUROBLASTOMA; NEUTROPHIL COUNT; OSTEOSARCOMA; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SPLEEN; STOMACH CANCER; THROMBOCYTE COUNT; TUBERCULOUS SPONDYLITIS;

BIOLOGICAL TRANSPORT; BONE MARROW; DIFFUSION; FEMALE; FLUORODEOXYGLUCOSE F18; HEMATOLOGIC TESTS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SPLEEN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77957344599     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181ef0905     Document Type: Article

References (21)

1. Liu Y. Clinical significance of diffusely increased splenic uptake on FDG-PET. Nucl Med Commun. 2009;30:763-769.
2. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2 deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847-850.
3. Kotzerke J, Guhlmann A, Moog F, et al. Role of attenuation correction for fluorine-18-fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med. 1999;26:31-38.
4. Meier JM, Alavi A, Iruvuri S, et al. Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography. Semin Nucl Med. 2007;37:154-172. (Pubitemid 46517469)
5. Rini J, Manalili EY, Hoffman MA, et al. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin Nucl Med. 2002; 27:572-577.
6. Kawai S, Ikeda E, Sugiyama M, et al. Enhancement of splenic glucose metabolism during acute malarial infection: correlation of findings of FDG-PET imaging with pathological changes in a primate model of severe human malaria. Am J Trop Med Hyg. 2006;74:353-360.
7. Naheel A, Yun M, Alavi A. F-18 FDG uptake in congestive splenomegaly. Clin Nucl Med. 2002;27:210.
8. Tomas MB, Tronco GG, Karayalcin G, et al. FDG uptake in infectious mononucleosis. Clin Positron Imaging. 2000;3:176.
9. Lustberg MB, Aras O, Meisenberg BR. FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma. Eur J Haematol. 2008;81: 154-156.
10. Sheehy N, Israel DA. Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT. Clin Nucl Med. 2007;32:820-821.
11. Burrell SC, Fischman AJ. Myelofibrosis on F-18 FDG PET imaging. Clin Nucl Med. 2005;30:674.
12. Wong CL, Fulham MJ. Increased splenic FDG uptake on PET in beta-thalassemia. Clin Nucl Med. 2004;29:266-267.
13. Maruoka H, Koga T, Takeo M, et al. Increased splenic fluorodeoxyglucose uptake in a patient with granulomatous angitis. Intern Med. 2007;46:909-911.
14. 18F-FDG PET/CT. J Nucl Med. 2005;46:52-59.
15. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426-431.
16. Sugawara Y, Zasodny KR, Kison PV, et al. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med. 1999;40:1456-1462.
17. Morooka M, Kubota K, Murata Y, et al. 18F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors. Ann Nucl Med. 2008;22:635-639.
18. Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004;45:1431-1434.
19. Inoue K, Goto R, Okada K, et al. A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity. Ann Nucl Med. 2009;23:643-649.
20. 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT. Nucl Med Biol. 2006;33:999-1004.
21. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.